Pharmaceuticals

Pentavalent Market Size and Growth Forecast for Businesses 2025–2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Pentavalent Market?

The pentavalent market has experienced consistent expansion in recent years. It is projected to increase from $2.62 billion in 2024 to $2.7 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.4%. This historical growth can be attributed to global immunization initiatives, government vaccination programs, the prevention of multiple diseases, increased public health awareness, and strong international partnerships and funding.

The pentavalent market is anticipated to show consistent growth over the next few years, reaching $3.24 billion in 2029 with a compound annual growth rate (CAGR) of 4.6%. This expansion during the forecast period is propelled by ongoing global immunization endeavors, the broadening of vaccination programs, entry into new geographical regions, research and development efforts, and partnerships for wider vaccine availability. Significant trends expected in this period involve worldwide health initiatives and financial backing, public information and educational campaigns, governmental policies and regulatory structures, and advancements in vaccine production technology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9104&type=smp

What Are The Main Drivers Boosting The Pentavalent Industry’s Expansion?

The increasing incidence of diphtheria is projected to stimulate expansion within the pentavalent market. Diphtheria is a serious and highly contagious illness caused by the bacterium Corynebacterium diphtheriae, leading to significant challenges with eating and breathing, alongside potential skin ulcers. The pentavalent vaccine offers protection against diphtheria in children via a 3-dose immunization schedule, thus the growing prevalence of the disease has amplified the need for these vaccines. For example, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported an exceptionally high volume of diphtheria cases through the International Health Regulations (IHR) reporting process in 2022, notably during June and August 2022. Across seven nations, 144 instances of diphtheria were documented, many occurring among asylum seekers. Out of these 144 patients, 97 (69%) were classified as clinically compatible, 44 (31%) were confirmed as toxigenic diphtheria cases through laboratory testing, and 3 (2%) remained suspected cases. Consequently, the escalating occurrence of diphtheria is propelling the growth of the pentavalent market.

What Are The Key Segments In The Pentavalent Market?

The pentavalent market covered in this report is segmented –

1) By Type: Sodium Stibogluconate, Meglumine Antimoniate

2) By Formulation Type: Lyophilized, Liquid

3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Sodium Stibogluconate: Injectable Form, Oral Form, Other Formulations

2) By Meglumine Antimoniate: Injectable Form, Oral Form, Other Formulations

Which Trends Are Impacting The Pentavalent Market?

Product innovation has emerged as a significant trend gaining traction within the pentavalent market. Key companies active in the pentavalent market are developing innovative products to solidify their market standing. For instance, in December 2022, Pfizer, a US-based pharmaceutical company operating in the pentavalent vaccines market, secured approval from The United States Food and Drug Administration, a US-based federal agency of the Department of Health and Human Services, for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) for Adolescents. This vaccine is indicated for the prevention of meningococcal disease in individuals aged 10 to 25. The unique aspect of the MenABCWY vaccine is its combination of components from two vaccines into one, offering protection against the meningococcal serogroups that cause the majority of invasive meningococcal diseases.

Which Leading Players Are Enhancing Their Pentavalent Market Presence Worldwide?

Major companies operating in the pentavalent market include Pfizer Inc., Merck & Co Inc., Sanofi SA, GlaxoSmithKline plc, Shandong Xinhua Pharmaceutical Company Limited, PT Bio Farma (Persero), Shantha Biotechnics Limited, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, PanGen Biotech Inc., Bharat Biotech International Limited, Vacsera Ltd., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

What Are The Regional Market Dynamics Impacting The Pentavalent Industry?

Asia-Pacific was the largest region in the pentavalent market in 2024. The regions covered in the pentavalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pentavalent Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9104&type=smp

Browse Through More Reports Similar to the Global Pentavalent Market 2025, By The Business Research Company

Diuretics Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

Carbon And Graphite Product Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/carbon-and-graphite-product-global-market-report

Carbon Dioxide Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/carbon-dioxide-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795